LimbLab

ASU
homepeopleprojectspublicationscollaboratorseducationopportunitieslinkscontact

neuroprosthesis

Restoring motor function following spinal cord injury

        Experimental spinal cord injury treatments generally fall into two categories: regrowth or repair of the spinal cord at the lesion site, and technological intervention to restore function below the lesion.

        The failure of adult spinal cord axons to regenerate through the lesion site is likely caused by multiple factors, such as the inability of the differentiated adult neurons and their axons to regrow along the correct pathway, the environment around the lesion site lacking the necessary growth facilitating signals, and the inhibitory nature of the glial scar (Caroni, 1988; Bovolenta, 1992; Behar, 2000, Zheng, 2003, Chen, 2000). To encourage axon regeneration following SCI, the hostile environment around the site of the injury needs to be converted to a permissive one that will enable lesioned axons to regenerate across the lesion site. Additionally, once the axons extend through the glial scar and into the adjacent tissue, they then need to reach appropriate targets that can restore function. Consequently, we seek to use cellular and pharmacological techniques to encourage spinal cord regrowth or repair following injury.

        Of the technological solutions, functional electrical stimulation promises to be an effective technique  to restore function. In the case of locomotion, FES systems seek to replace or augment the injured spinal cord’s pattern-generating capacity with an artificial signal generator. The form of this signal generator varies (Abbas and Chizeck, 1995; Davoodi and Andrews, 2004; Riener et al., 2000), but considering the complexity of the musculoskeletal system future generations of controllers are likely to require a model of the segment of the musculoskeletal system they are designed to control. Substantial progress has been made towards developing FES control systems that use mathematical models to account for the complex dynamics of the musculoskeletal system (Abbas and Chizeck, 1995). However, developing, validating, and testing FES control systems directly in humans is extremely challenging. Practical and ethical considerations limit the number and types of experiments that can be carried out. An animal model for FES system development would greatly facilitate the development and testing of novel control systems, and potentially also allow the effects of combining FES with therapies designed to stimulate re-growth or repair of the spinal cord. Due to the widespread use of the rat in research on SCI the rat would be a practical model system for FES controller design, and offer tremendous potential for discovering how FES could contribute to restoring function following SCI in a broader therapeutic context.